Literature DB >> 36169857

Conventional Receptor Radioligand Binding Techniques Applied to the Study of Monoamine Oxidase.

Andrew Holt1.   

Abstract

Designed to measure binding interactions between small molecules and receptor proteins, radioligand binding approaches may also be applied to interactions between monoamine oxidase (MAO) and its ligands. The technique may be used with tissue homogenates or with mitochondrial membranes and can provide information about binding site density, ligand affinity, binding rate constants, and binding events at sites that do not impact absorbance characteristics of the flavin cofactor and that may not be amenable to spectrophotometric studies. This overview describes the use of a cell harvester in a common filtration approach to measure binding to MAO of radiolabeled substrates, inhibitors, or allosteric ligands in saturation analyses and to take advantage of the principles of competition to obtain quantitative binding data for unlabeled ligands that may bind with much lower affinity. The quality and reproducibility of data are impacted by factors such as choice of ligand concentrations, pipetting technique, graphing and regression approaches, and scintillation counting parameters, and consideration is given to these and other factors that may influence the results.
© 2023. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Bmax; Cell harvester; Filtration; KD; Liquid scintillation counting; Monoamine oxidase; Radioligand binding

Mesh:

Substances:

Year:  2023        PMID: 36169857     DOI: 10.1007/978-1-0716-2643-6_7

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  41 in total

1.  Further studies on the inhibition of monoamine oxidase by M and B 9302 (clorgyline). I. Substrate specificity in various mammalian species.

Authors:  D W Hall; B W Logan; G H Parsons
Journal:  Biochem Pharmacol       Date:  1969-06       Impact factor: 5.858

Review 2.  Quantitative analysis of drug-receptor interactions: I. Determination of kinetic and equilibrium properties.

Authors:  G A Weiland; P B Molinoff
Journal:  Life Sci       Date:  1981-07-27       Impact factor: 5.037

3.  Electrophoretic characterization of monoamine oxidase by [3H]pargyline binding in rat hepatoma cells with A and B activity.

Authors:  M R Costa; X O Breakefield
Journal:  Mol Pharmacol       Date:  1979-07       Impact factor: 4.436

4.  Characterization of monoamine oxidase activity present in human granulocytes and lymphocytes.

Authors:  M D Balsa; N Gómez; M Unzeta
Journal:  Biochim Biophys Acta       Date:  1989-08-18

Review 5.  Biochemistry and pharmacology of moclobemide, a prototype RIMA.

Authors:  W Haefely; W P Burkard; A M Cesura; R Kettler; H P Lorez; J R Martin; J G Richards; R Scherschlicht; M Da Prada
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

6.  Monoclonal antibodies to monoamine oxidase B and another mitochondrial protein from human liver.

Authors:  E E Billett; R J Mayer
Journal:  Biochem J       Date:  1986-04-01       Impact factor: 3.857

7.  Platelet monoamine oxidase: specific activity and turnover number in headache.

Authors:  K M Summers; G K Brown; I W Craig; J Littlewood; R Peatfield; V Glover; F C Rose; M Sandler
Journal:  Clin Chim Acta       Date:  1982-05-20       Impact factor: 3.786

8.  In vitro and in vivo inhibition by benserazide of clorgyline-resistant amine oxidases in rat cardiovascular tissues.

Authors:  G A Lyles; B A Callingham
Journal:  Biochem Pharmacol       Date:  1982-04-01       Impact factor: 5.858

9.  Studies on the pargyline-binding site of different types of monoamine oxidase.

Authors:  P H Yu
Journal:  Can J Biochem       Date:  1981-01

10.  Translation Imaging in Parkinson's Disease: Focus on Neuroinflammation.

Authors:  Sara Belloli; Michele Morari; Valentina Murtaj; Silvia Valtorta; Rosa Maria Moresco; Maria Carla Gilardi
Journal:  Front Aging Neurosci       Date:  2020-06-05       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.